Speaker Dr. Annemarie Moseley, CEO of Aggregate Therapeutics (Palo Alto) explores how drug-device combination products are altering the medical practice from development to regulation to treatment. Part of the MaRS Emerging Technologies Event Series. More information on the series can be found here: http://www.marsdd.com/emergingtech/